{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.3956.3956",
    "article_title": "Preexisting Mutations in Hematopoietic Stem Cells in Patients with Therapy-Related Myeloid Neoplasms ",
    "article_date": "December 7, 2017",
    "session_type": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III",
    "abstract_text": "Introduction : Recently, it has been suggested that some hematopoietic stem cell clones (HSC) harbor preexisting genomic mutations which could be selected for antineoplastic treatments received against a first neoplasm (1 st -neo) that might, eventually, lead the development of therapy-related myeloid neoplasms (TRMN). Aim: To analyze genetic mutational profile in a cohort of patients with TRMN from different national centers. To determine the presence of preexisting mutations in HSC by deep massive sequencing: genetic composition and evolutive behavior. Methods : We studied 103 patients with TRMN from 6 national hospitals. The average age was 62 years old (range: 31-89); 45% were men; as 1 st -neo: 36% were breast cancer, 34% lymphoma, 5% multiple myeloma and 25% other type of neoplasm. In 18 patients, a paired sample of bone marrow at the moment of the 1 st -neo was available [previous disease: lymphoma (n=13), multiple myeloma (n=4), breast cancer neo (n=1)]. We sequenced the complete coding region of the genes: BCOR, BRAF, CDKN2A, CEBPA, DNMT3A, ETV6, EZH2, GNAS, LUC7L2, NF1, PHF6, PTPN11, RAD21, RPS14, SF1, SF3A1, SMC3, SPARC, SRSF2, STAG2 and ZRSR2 and the hotspot regions of genes: ASXL1, MPL, NPM1, JAK2, KRAS, NRAS, TET2, U2AF1, KIT, IDH1, RUNX1, IDH2, SETBP1, TP53, WT1, CBL, SF3B1 and FLT3 with a custom amplicon panel (Ampliseq). Variants were selected according to VAF\u22651%, MAF<0,01 and its effects upon the protein. Depth coverage in 1 st -neo samples was 10,000x and 2,000x for TRMN. Results: At least one variation was detected in the studied genes in 98% of patients with TRMN (n=101) [321 mutations (263 missense and 58 indels); 3,2 mut/pa (0-12)]. Most frequently mutated genes were TP53 (35%), TET2 (32%), DNMT3A (17%), RAD21 (14%), SETBP1 (12%), IDH2 (8%), SF3B1 (8%) and SRSF2 (7%). Half of the patients with paired sample harbored mutations in the 1 st -neo sample (14/18). In total, 27 pathologic variations were detected in these samples (24 SNV and 3 indels). In 4 cases, mutations prevailed after evolution (22%), increasing their variant allelic frequency (VAF) and suggesting the selection of a preexisting clone after antineoplastic treatment (Table 1). Conclusions: At least one variation in the studied genes was detected in 98% of the patients with TRMN, being TP53 mutations the most frequent (35%). In 22% of the cases with paired sample was confirmed the expansion of a clone present in the apparently normal bone marrow at the moment of the first neoplasm, suggesting a possible mechanism of selective pressure in the context of the received antineoplastic therapy. Research funded by CIBERONC CB16/12/00284, PI12/01047, RD12/0036/0014, PIE13/00046, PI13/01640, PI13/02837, PT13/0010/0026, PI14/01649, AC15/00068, PI16/011113 and PI16/00665. View large Download slide View large Download slide  Close modal Disclosures Montesinos: Celgene Corporation: Honoraria, Research Funding. Sanz: Gamida Cell: Research Funding.",
    "topics": [
        "hematopoietic stem cells",
        "mutation",
        "neoplasms",
        "protein p53",
        "breast cancer",
        "lymphoma",
        "multiple myeloma",
        "ccaat/enhancer binding protein alpha",
        "ms-like tyrosine kinase 3",
        "protein p16"
    ],
    "author_names": [
        "Mariam Iba\u00f1ez",
        "Maria L\u00f3pez-Pav\u00eda",
        "Esperanza Such",
        "Blanca Navarro",
        "Alexander Neef, PhD",
        "Javier Marco",
        "Mireia Boluda-Navarro",
        "Marta Llop",
        "Claudia Sargas",
        "Beatricce De Matteo",
        "Alessandro Liquori, PhD",
        "Elisa Gonzalez",
        "Andres Jerez",
        "David Valc\u00e1rcel",
        "Julia Montoro",
        "Maria D\u00edez-Campelo",
        "Jes\u00fas-Mar\u00eda Hern\u00e1ndez-Rivas, MD PhD",
        "Jesus M Hern\u00e1ndez-S\u00e1nchez",
        "Teresa Bernal Del Castillo, MD PhD",
        "Alejandra Sanjuan, PhD",
        "Pau Montesinos, MD PhD",
        "Eva Barrag\u00e1n",
        "Miguel A. Sanz, MD",
        "Jos\u00e9 Cervera, MD PhD",
        "Guillermo Sanz, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Mariam Iba\u00f1ez",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Maria L\u00f3pez-Pav\u00eda",
            "author_affiliations": [
                "Hospital General Universitari de Val\u00e8ncia, Hematology Service, Valencia, Spain "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Esperanza Such",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Blanca Navarro",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alexander Neef, PhD",
            "author_affiliations": [
                "IISLAFE, Grupo de Investigaci\u00f3n Hematolog\u00eda, Valencia, Spain "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Javier Marco",
            "author_affiliations": [
                "Servicio Hematologia Hospital La Fe, Valencia, Spain "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mireia Boluda-Navarro",
            "author_affiliations": [
                "Grupo de Investigaci\u00f3n Hematologia. IISLAFE, Valencia, Spain "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marta Llop",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Claudia Sargas",
            "author_affiliations": [
                "Grupo Investigaci\u00f3n Hematologia. IISLAFE, Valencia, Spain "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Beatricce De Matteo",
            "author_affiliations": [
                "Grupo Investigaci\u00f3n Hematologia. IISLAFE, VALENCIA, Spain "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Liquori, PhD",
            "author_affiliations": [
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisa Gonzalez",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andres Jerez",
            "author_affiliations": [
                "Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, MURCIA, Spain "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "David Valc\u00e1rcel",
            "author_affiliations": [
                "Hospital Universitario Vall d'Hebron, Barcelona, Spain "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Julia Montoro",
            "author_affiliations": [
                "Hospital Universitario Valle de Hebr\u00f3n, Barcelona, Spain "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria D\u00edez-Campelo",
            "author_affiliations": [
                "Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jes\u00fas-Mar\u00eda Hern\u00e1ndez-Rivas, MD PhD",
            "author_affiliations": [
                "IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, Salamanca, Spain ",
                "Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jesus M Hern\u00e1ndez-S\u00e1nchez",
            "author_affiliations": [
                "IBSAL, IBMCC, CIC, Universidad de Salamanca-CSIC, Salamanca, Spain "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Teresa Bernal Del Castillo, MD PhD",
            "author_affiliations": [
                "Fundaci\u00f3n General de la Universidad de Salamanca, Oviedo, ESP "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alejandra Sanjuan, PhD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pau Montesinos, MD PhD",
            "author_affiliations": [
                "CIBERONC, madrid, Spain ",
                "Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eva Barrag\u00e1n",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Miguel A. Sanz, MD",
            "author_affiliations": [
                "CIBERONC, Madrid, Spain ",
                "Hospital Univ. La Fe, Valencia, ESP "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jos\u00e9 Cervera, MD PhD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guillermo Sanz, MD",
            "author_affiliations": [
                "CIBERONC, Madrid, Spain ",
                "Hospital Universitario La Fe, Spanish MDS Cooperative Group, Valencia, Spain ",
                "GESMD, Valencia, Spain"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-11T09:33:56",
    "is_scraped": "1"
}